Advertisement

Medical Oncology

, Volume 28, Supplement 1, pp 62–64 | Cite as

Phyllodes tumor of the breast

  • Grzegorz Korpanty
  • Derek G. Power
  • Conleth Murphy
  • Malcolm Kell
  • John McCaffrey
Article

Abstract

We present a case of 49-year-old woman who presented with a three month history of progressive right-sided breast pain and swelling and was found with bulky tumor at her initial presentation. She was diagnosed with phyllodes tumor of her breast and treated initially with neoadjuvant chemotherapy and mastectomy. We discuss recent advances in diagnosis and management of breast phyllodes tumors.

Keywords

Phyllodes breast cancer 

References

  1. 1.
    Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology. 2008;52:45–57.PubMedCrossRefGoogle Scholar
  2. 2.
    Reinfuss M, Mitus J, Duda K, Stelmach A, Rys J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer. 1996;77:910–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Barrio AV, Clark BD, Goldberg JI, et al. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Ann Surg Oncol. 2007;14:2961–70.PubMedCrossRefGoogle Scholar
  4. 4.
    Belkacemi Y, Bousquet G, Marsiglia H, et al. Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys. 2008;70:492–500.PubMedCrossRefGoogle Scholar
  5. 5.
    Ben Hassouna J, Damak T, Gamoudi A, et al. Phyllodes tumors of the breast: a case series of 106 patients. Am J Surg. 2006;192:141–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91:185–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Abdalla HM, Sakr MA. Predictive factors of local recurrence and survival following primary surgical treatment of phyllodes tumors of the breast. J Egypt Natl Canc Inst. 2006;18:125–33.PubMedGoogle Scholar
  8. 8.
    Kapiris I, Nasiri N, A’Hern R, Healy V, Gui GP. Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol. 2001;27:723–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Pezner RD, Schultheiss TE, Paz IB. Malignant phyllodes tumor of the breast: local control rates with surgery alone. Int J Radiat Oncol Biol Phys. 2008;71:710–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Jones AM, Mitter R, Springall R, et al. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence. J Pathol. 2008;214:533–44.PubMedCrossRefGoogle Scholar
  11. 11.
    Lae M, Vincent-Salomon A, Savignoni A, Huon I, Freneaux P, Sigal-Zafrani B, et al. Phyllodes tumors of the breast segregate in two groups according to genetic criteria. Mod Pathol. 2007;20(4):435–44.PubMedCrossRefGoogle Scholar
  12. 12.
    Grabowski J, Salzstein SL, Sadler GR, Blair SL. Malignant phyllodes tumors: a review of 752 cases. Am Surg. 2007;73:967–9.PubMedGoogle Scholar
  13. 13.
    Morales-Vasquez F, Gonzalez-Angulo AM, Broglio K, et al. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast. Breast J. 2007;13:551–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Chaney AW, Pollack A, McNeese MD, Zagars GK. Adjuvant radiotherapy for phyllodes tumor of breast. Radiat Oncol Investig. 1998;6:264–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Soumarova R, Seneklova Z, Horova H, et al. Retrospective analysis of 25 women with malignant cystosarcoma phyllodes–treatment results. Arch Gynecol Obstet. 2004;269:278–81.PubMedCrossRefGoogle Scholar
  16. 16.
    Macdonald OK, Lee CM, Tward JD, Chappel CD, Gaffney DK. Malignant phyllodes tumor of the female breast: association of primary therapy with cause-specific survival from the Surveillance, Epidemiology, and End Results (SEER) program. Cancer. 2006;107:2127–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Grzegorz Korpanty
    • 1
  • Derek G. Power
    • 1
  • Conleth Murphy
    • 1
  • Malcolm Kell
    • 2
  • John McCaffrey
    • 1
  1. 1.Department of Medical OncologyMater Misericordiae University HospitalDublinIreland
  2. 2.Department of Breast SurgeryMater Misericordiae University HospitalDublinIreland

Personalised recommendations